Tarsus Pharmaceuticals, Inc. (TARS) NASDAQ
62.75
-0.7302(-1.15%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
62.75
-0.7302(-1.15%)
Currency In USD
| Market Cap | 3.42B |
| Enterprise Value | 3.33B |
| P/E Ratio | -40.45 |
| PEG Ratio | -0.55 |
| Price/Sales Ratio | 5.92 |
| Price/Book Ratio | 7.82 |
| Enterprise/Revenue | 5.72 |
| Enterprise/EBITDA | -46.18 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.15 |
| Operating Margin | -0.16 |
| Return On Assets | -0.12 |
| Return On Equity | -0.2 |
| Revenue | 451.36M |
| Revenue/Share | 10.55 |
| Gross Profit | 420.68M |
| EBITDA | -53.61M |
| Net Income | -66.42M |
| Diluted EPS | -1.59 |
| Total Cash | 417.27M |
| Total Cash/Share | 9.75 |
| Total Debt | 93.64M |
| Total Debt/Equity | 0.27 |
| Current Ratio | 3.85 |
| Book Value Per Share | 8.03 |
| 52-Week Change | 25.5 |
| 52-Week High | 85.25 |
| 52-Week Low | 38.51 |
| Moving Average 50 Days | 69.21 |
| Moving Average 200 Days | 65.37 |
| Average Volume | 558,083 |
| Shares Outstanding | 42.56M |
| % Held by Institutions | 103.39 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |